PackGene and Kudo Bio Partner to Provide End-to-End mRNA Services
publication date: Sep 19, 2023
Boston’s PackGene Biotech partnered with Kudo Biotechnology, headquartered in Singapore, to provide end-to-end customized messenger RNA manufacturing services for drug and vaccine development. PackGene will offer process development and manufacturing services for plasmid DNA and cell banking, while Kudo Bio will provide process development, analytical development and manufacturing of mRNA and LNP, as well as fill and finish. PackGene has a GMP plasmid production site in Guangzhou, and Kudo’s Shanghai operations include clinical GMP manufacturing facility and MSAT laboratories. The partnership expects to reduce development times for novel mRNA products. More details....
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.